Sixfold Bioscience develops and researches on biotechnology advances for RNA therapies.
Sixfold Bioscience's investors include Y Combinator, Cantos, Bossa Invest, Innovate UK, European Commission.
Sixfold Bioscience is headquartered in London, United Kingdom.
Sixfold Bioscience develops and researches on biotechnology advances for RNA therapies.
Sixfold Bioscience is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sixfold Bioscience — Funding & Investors." VCBacked, December 2, 2021, https://www.vcbacked.co/company/sixfold-bioscience. Accessed September 29, 2026.
VCBacked. (2021). Sixfold Bioscience — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/sixfold-bioscience
{{cite web |title=Sixfold Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/sixfold-bioscience |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated